Liquid chromatography-tandem mass spectrometric assay for the T790M mutant EGFR inhibitor osimertinib (AZD9291) in human plasma

Johannes J M Rood*, Mark T J van Bussel, Jan H M Schellens, Jos H Beijnen, Rolf W Sparidans

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'Liquid chromatography-tandem mass spectrometric assay for the T790M mutant EGFR inhibitor osimertinib (AZD9291) in human plasma'. Together they form a unique fingerprint.

Keyphrases

Chemistry

Pharmacology, Toxicology and Pharmaceutical Science